You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Genuity, formerly known as WuXi NextCode, will sequence, analyze, and harmonize samples from Vanderbilt's biobank to inform biomarker and drug discovery.
Based in Boston with operations in Ireland and Iceland, the reorganized company is supporting COVID-19 testing and population genomics as it sheds its China division.
Facing questions over data security in the US and Ireland, the company has changed its name as it looks to shed its China operations.
In an opinion piece in the Irish Times, Anne Jones, the chief executive of Genomics Medicine Ireland, argues that Ireland needs private investment in genomic medicine.
The firm is reassuring participants that their data is secure following media coverage highlighting GMI's position as a fully-owned subsidiary of WuXi NextCode.
Two senators have asked a government watchdog to see if CMS made payments to US providers who have partnered with firms including WuXi NextCode and BGI.
The company said it will use the funds to expand its operations in Ireland, which it established through the recent acquisition of Genomics Medicine Ireland.
WuXi's data analysis tools will be hosted on Google's Cloud marketplace while Google's genomics and research tools will be integrated with WuXi's platform.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.